In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease

Developing a safe and effective antiviral treatment takes a decade, however, when it comes to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the pandemic. Screening approved antiviral drugs against COVID-19 would speed the process of finding therapeutic treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Khater, Ibrahim, Nassar, Aaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173495/
https://www.ncbi.nlm.nih.gov/pubmed/34099985
http://dx.doi.org/10.1016/j.bbrep.2021.101032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173495/
https://www.ncbi.nlm.nih.gov/pubmed/34099985
http://dx.doi.org/10.1016/j.bbrep.2021.101032

Ejemplares similares